Corticotropin-releasing factor in the nucleus accumbens shell induces swim depression, anxiety, and anhedonia along with changes in local dopamine/acetylcholine balance

Neuroscience

Volumn 206, Issue , 2012, Pages 155-166

  Chen, Y W ^a   Rada, P V ^a,b   Butzler B P ^a   Leibowitz, S F ^c   Hoebel, B G ^a  

^a PRINCETON UNIVERSITY   (United States)

^b UNIVERSIDAD DE LOS ANDES   (Venezuela)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Acetylcholine; Anxiety; CRF; Depression; Dopamine; Nucleus accumbens

Indexed keywords

ACETYLCHOLINE; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; SUCROSE;

ACETYLCHOLINE BRAIN LEVEL; AMYGDALOID NUCLEUS; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; AVERSIVE BEHAVIOR; BEHAVIOR CHANGE; CONTROLLED STUDY; DEPRESSION; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; EXTRACELLULAR SPACE; FORCED SWIMMING TEST; IN VIVO STUDY; LOCOMOTION; MALE; MAZE TEST; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; NUCLEUS ACCUMBENS SHELL; PRIORITY JOURNAL; RAT; TASTE PREFERENCE;

ACETYLCHOLINE; ANHEDONIA; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CORTICOTROPIN-RELEASING HORMONE; DEPRESSION; DOPAMINE; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84862777424     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.12.009     Document Type: Article

References (77)

1. Amargos-Bosch M., Adell A., Bortolozzi A., Artigas F. Stimulation of alpha1-adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: reversal by antipsychotic drugs. J Neurochem 2003, 87:831-842.
2. Diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000, American Psychiatric Association.
3. Avena N.M., Bocarsly M.E., Rada P., Kim A., Hoebel B.G. After daily bingeing on a sucrose solution, food deprivation induces anxiety and accumbens dopamine/acetylcholine imbalance. Physiol Behav 2008, 94:309-315.
4. Avena N.M., Rada P., Moise N., Hoebel B.G. Sucrose sham feeding on a binge schedule releases accumbens dopamine repeatedly and eliminates the acetylcholine satiety response. Neuroscience 2006, 139:813-820.
5. Barrot M., Olivier J.D., Perrotti L.I., DiLeone R.J., Berton O., Eisch A.J., Impey S., Storm D.R., Neve R.L., Yin J.C., Zachariou V., Nestler E.J. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci U S A 2002, 99:11435-11440.
6. Bewernick B.H., Hurlemann R., Matusch A., Kayser S., Grubert C., Hadrysiewicz B., Axmacher N., Lemke M., Cooper-Mahkorn D., Cohen M.X., Brockmann H., Lenartz D., Sturm V., Schlaepfer T.E. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 2010, 67:110-116.
7. Bromberg-Martin E.S., Matsumoto M., Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 2010, 68:815-834.
8. Cabib S., Puglisi-Allegra S. Opposite responses of mesolimbic dopamine system to controllable and uncontrollable aversive experiences. J Neurosci 1994, 14:3333-3340.
9. Chau D.T., Rada P., Kosloff R.A., Taylor J.L., Hoebel B.G. Nucleus accumbens muscarinic receptors in the control of behavioral depression: antidepressant-like effects of local M1 antagonist in the Porsolt swim test. Neuroscience 2001, 104:791-798.
10. Claustre Y., Rouquier L., Desvignes C., Leonetti M., Montégut J., Aubin N., Allouard N., Bougault I., Oury-Donat F., Steinberg R. Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat. Neuroscience 2006, 141:1481-1488.
11. Dallman M.F., Pecoraro N., Akana S.F., La Fleur S.E., Gomez F., Houshyar H., Bell M.E., Bhatnagar S., Laugero K.D., Manalo S. Chronic stress and obesity: a new view of "comfort food". Proc Natl Acad Sci U S A 2003, 100:11696-11701.
12. Day J.C., Koehl M., Le Moal M., Maccari S. Corticotropin-releasing factor administered centrally, but not peripherally, stimulates hippocampal acetylcholine release. J Neurochem 1998, 71:622-629.
13. Dazzi L., Motzo C., Maira G., Sanna A., Serra M., Biggio G. Enhancement of acetylcholine release by flumazenil in the hippocampus of rats chronically treated with diazepam but not with imidazenil or abecarnil. Psychopharmacology (Berl) 1995, 121:180-185.
14. Degroot A., Treit D. Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Brain Res 2002, 949:60-70.
15. Di Chiara G. Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res 2002, 137:75-114.
16. Dunn A.J., Swiergiel A.H., Palamarchouk V. Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress. Ann N Y Acad Sci 2004, 1018:25-34.
17. Faure A., Reynolds S.M., Richard J.M., Berridge K.C. Mesolimbic dopamine in desire and dread: enabling motivation to be generated by localized glutamate disruptions in nucleus accumbens. J Neurosci 2008, 28:7184-7192.
18. Fedeli A., Braconi S., Economidou D., Cannella N., Kallupi M., Guerrini R., Calò G., Cifani C., Massi M., Ciccocioppo R. The paraventricular nucleus of the hypothalamus is a neuroanatomical substrate for the inhibition of palatable food intake by neuropeptide S. Eur J Neurosci 2009, 30:1594-1602.
19. Gomez F., Graugés P., López-Calderón A., Armario A. Abnormalities of hypothalamic-pituitary-adrenal and hypothalamic-somatotrophic axes in Fawn-Hooded rats. Eur J Endocrinol 1999, 141:290-296.
20. Gorman A.L., Dunn A.J. Beta-adrenergic receptors are involved in stress-related behavioral changes. Pharmacol Biochem Behav 1993, 45:1-7.
21. Hernandez L., Guzman N.A., Hoebel B.G. Bidirectional microdialysis in vivo shows differential dopaminergic potency of cocaine, procaine and lidocaine in the nucleus accumbens using capillary electrophoresis for calibration of drug outward diffusion. Psychopharmacology (Berl) 1991, 105:264-268.
22. Hikida T., Kaneko S., Isobe T., Kitabatake Y., Watanabe D., Pastan I., Nakanishi S. Increased sensitivity to cocaine by cholinergic cell ablation in nucleus accumbens. Proc Natl Acad Sci U S A 2001, 98:13351-13354.
23. Hikida T., Kitabatake Y., Pastan I., Nakanishi S. Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci U S A 2003, 100:6169-6173.
24. Hoebel B.G., Avena N.M., Rada P. Accumbens dopamine-acetylcholine balance in approach and avoidance. Curr Opin Pharmacol 2007, 7:617-627.
25. Holahan M.R., Kalin N.H., Kelley A.E. Microinfusion of corticotropin-releasing factor into the nucleus accumbens shell results in increased behavioral arousal and oral motor activity. Psychopharmacology (Berl) 1997, 130:189-196.
26. Izzo E., Sanna P.P., Koob G.F. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor. Pharmacol Biochem Behav 2005, 81:701-708.
27. Ji G., Fu Y., Ruppert K.A., Neugebauer V. Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol Pain 2007, 3:13.
28. Keen-Rhinehart E., Michopoulos V., Toufexis D.J., Martin E.I., Nair H., Ressler K.J., Davis M., Owens M.J., Nemeroff C.B., Wilson M.E. Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes. Mol Psychiatry 2009, 14:37-50.
29. Kim K.S., Lee K.W., Baek I.S., Lim C.M., Krishnan V., Lee J.K., Nestler E.J., Han P.L. Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior. J Neurochem 2008, 107:105-115.
30. Koob G.F. The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res 2010, 1314:3-14.
31. Kreibich A.S., Briand L., Cleck J.N., Ecke L., Rice K.C., Blendy J.A. Stress-induced potentiation of cocaine reward: a role for CRF R1 and CREB. Neuropsychopharmacology 2009, 34:2609-2617.
32. Lim M.M., Liu Y., Ryabinin A.E., Bai Y., Wang Z., Young L.J. CRF receptors in the nucleus accumbens modulate partner preference in prairie voles. Horm Behav 2007, 51:508-515.
33. Lu L., Liu Z., Huang M., Zhang Z. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. J Neurochem 2003, 84:1378-1386.
34. Magalhaes A.C., Holmes K.D., Dale L.B., Comps-Agrar L., Lee D., Yadav P.N., Drysdale L., Poulter M.O., Roth B.L., Pin J.P., Anisman H., Ferguson S.S. CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. Nat Neurosci 2010, 13:622-629.
35. Marcinkiewcz C.A., Prado M.M., Isaac S.K., Marshall A., Rylkova D., Bruijnzeel A.W. Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. Neuropsychopharmacology 2009, 34:1743-1752.
36. Mark G.P., Rada P., Pothos E., Hoebel B.G. Effects of feeding and drinking on acetylcholine release in the nucleus accumbens, striatum, and hippocampus of freely behaving rats. J Neurochem 1992, 58:2269-2274.
37. Mark G.P., Weinberg J.B., Rada P.V., Hoebel B.G. Extracellular acetylcholine is increased in the nucleus accumbens following the presentation of an aversively conditioned taste stimulus. Brain Res 1995, 688:184-188.
38. Martinez G., Ropero C., Funes A., Flores E., Blotta C., Landa A.I., Gargiulo P.A. Effects of selective NMDA and non-NMDA blockade in the nucleus accumbens on the plus-maze test. Physiol Behav 2002, 76:219-224.
39. Menzaghi F., Howard R.L., Heinrichs S.C., Vale W., Rivier J., Koob G.F. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J Pharmacol Exp Ther 1994, 269:564-572.
40. Merchenthaler I. Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides 1984, 5(Suppl 1):53-69.
41. Merchenthaler I., Vigh S., Petrusz P., Schally A.V. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am J Anat 1982, 165:385-396.
42. Mifsud J.C., Hernandez L., Hoebel B.G. Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res 1989, 478:365-367.
43. Mogenson G.J., Jones D.L., Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 1980, 14:69-97.
44. Muschamp J.W., Van't Veer A., Parsegian A., Gallo M.S., Chen M., Neve R.L., Meloni E.G., Carlezon W.A. Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats. J Neurosci 2011, 31:3095-3103.
45. Nair H.P., Gutman A.R., Davis M., Young L.J. Central oxytocin, vasopressin, and corticotropin-releasing factor receptor densities in the basal forebrain predict isolation potentiated startle in rats. J Neurosci 2005, 25:11479-11488.
46. Pascucci T., Ventura R., Latagliata E.C., Cabib S., Puglisi-Allegra S. The medial prefrontal cortex determines the accumbens dopamine response to stress through the opposing influences of norepinephrine and dopamine. Cereb Cortex 2007, 17:2796-2804.
47. Pecina S., Schulkin J., Berridge K.C. Nucleus accumbens corticotropin-releasing factor increases cue-triggered motivation for sucrose reward: paradoxical positive incentive effects in stress?. BMC Biol 2006, 4:8.
48. Pennartz C.M., Groenewegen H.J., Lopes da Silva F.H. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog Neurobiol 1994, 42:719-761.
49. Perrin M.H., Sutton S.W., Cervini L.A., Rivier J.E., Vale W.W. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. J Pharmacol Exp Ther 1999, 288:729-734.
50. Pliakas A.M., Carlson R.R., Neve R.L., Konradi C., Nestler E.J., Carlezon W.A. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 2001, 21:7397-7403.
51. Primus R.J., Yevich E., Baltazar C., Gallager D.W. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology 1997, 17:308-316.
52. Rada P., Jensen K., Hoebel B.G. Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens. Psychopharmacology (Berl) 2001, 157:105-110.
53. Rada P., Pothos E., Mark G.P., Hoebel B.G. Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine. Brain Res 1991, 561:354-356.
54. Rada P.V., Mark G.P., Taylor K.M., Hoebel B.G. Morphine and naloxone, i.p. or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex. Pharmacol Biochem Behav 1996, 53:809-816.
55. Regev L., Neufeld-Cohen A., Tsoory M., Kuperman Y., Getselter D., Gil S., Chen A. Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation. Mol Psychiatry 2011, 16:714-728.
56. Reynolds S.M., Berridge K.C. Positive and negative motivation in nucleus accumbens shell: bivalent rostrocaudal gradients for GABA-elicited eating, taste "liking"/"disliking" reactions, place preference/avoidance, and fear. J Neurosci 2002, 22:7308-7320.
57. Riegel A.C., Williams J.T. CRF facilitates calcium release from intracellular stores in midbrain dopamine neurons. Neuron 2008, 57:559-570.
58. Sauvage M., Steckler T. Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei-potential implication for arousal and attention. Neuroscience 2001, 104:643-652.
59. Schlaepfer T.E., Cohen M.X., Frick C., Kosel M., Brodesser D., Axmacher N., Joe A.Y., Kreft M., Lenartz D., Sturm V. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008, 33:368-377.
60. Shaham Y., Erb S., Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev 2000, 33:13-33.
61. Shepard J.D., Myers D.A. Strain differences in anxiety-like behavior: association with corticotropin-releasing factor. Behav Brain Res 2008, 186:239-245.
62. (9-41) on rat fear responses and amino acids release in the central nucleus of the amygdala. Neuropharmacology 2009, 57:148-156.
63. Spina M.G., Basso A.M., Zorrilla E.P., Heyser C.J., Rivier J., Vale W., Merlo-Pich E., Koob G.F. Behavioral effects of central administration of the novel CRF antagonist astressin in rats. Neuropsychopharmacology 2000, 22:230-239.
64. Steckler T., Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 1999, 46:1480-1508.
65. Stewart J. Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci 2000, 25:125-136.
66. Sturm V., Lenartz D., Koulousakis A., Treuer H., Herholz K., Klein J.C., Klosterkötter J. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat 2003, 26:293-299.
67. Swiergiel A.H., Zhou Y., Dunn A.J. Effects of chronic footshock, restraint and corticotropin-releasing factor on freezing, ultrasonic vocalization and forced swim behavior in rats. Behav Brain Res 2007, 183:178-187.
68. Takahashi L.K. Role of CRF(1) and CRF(2) receptors in fear and anxiety. Neurosci Biobehav Rev 2001, 25:627-636.
69. Taylor K.M., Mark G.P., Hoebel B.G. Conditioned taste aversion from neostigmine or methyl-naloxonium in the nucleus accumbens. Physiol Behav 2011, 104:82-86.
70. Threlfell S., Cragg S.J. Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons. Front Syst Neurosci 2011, 5:11.
71. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:1394-1397.
72. Valentino R.J., Lucki I., Van Bockstaele E. Corticotropin-releasing factor in the dorsal raphe nucleus: linking stress coping and addiction. Brain Res 2010, 1314:29-37.
73. Ventura R., Morrone C., Puglisi-Allegra S. Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuli. Proc Natl Acad Sci U S A 2007, 104:5181-5186.
74. Yang X.M., Dunn A.J. Central beta 1-adrenergic receptors are involved in CRF-induced defensive withdrawal. Pharmacol Biochem Behav 1990, 36:847-851.
75. Yang X.M., Gorman A.L., Dunn A.J. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats. J Pharmacol Exp Ther 1990, 255:1064-1070.
76. Zarrindast M.R., Babapoor-Farrokhran S., Rezayof A. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior. Life Sci 2008, 82:1175-1181.
77. Zorrilla E.P., Reinhardt L.E., Valdez G.R., Inoue K., Rivier J.E., Vale W.W., Koob G.F. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity. J Pharmacol Exp Ther 2004, 310:1027-1034.